Olaratumab for Sarcoma Under Review After Negative Trial Olaratumab for Sarcoma Under Review After Negative Trial

The product has been used in combination with doxorubicin in patients with soft tissue sarcoma, but negative results from a confirmatory trial put its future in question.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news